MSKCC

(redirected from Memorial Sloan-Kettering Cancer Center)
Also found in: Wikipedia.
AcronymDefinition
MSKCCMemorial Sloan-Kettering Cancer Center
References in periodicals archive ?
Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research, and education in cancer.
Memorial Sloan-Kettering Cancer Center (MSKCC) sought to develop a chemotherapy infusion center that streamlines and enhances the patient care experience.
"Investigators at Southern Research Institute, SRI International, and Memorial Sloan-Kettering Cancer Center worked together under the auspices of the National Cancer Institute for many years," said Robert Piper, Ph.D.
At Memorial Sloan-Kettering Cancer Center in New York, roughly 40% of patients undergoing treatment for cancer have coexisting CVD.
New York's Memorial Sloan-Kettering Cancer Center refused to confirm reports he was having treatment for lung cancer.
Kris, chief of the thoracic oncology service at Memorial Sloan-Kettering Cancer Center in New York.
Shah (Memorial Sloan-Kettering Cancer Center, New York), colleagues, and his pharmacist wife answer patients' questions regarding cancers of the upper gastrointestinal tract.
The study was conducted by the Center for Studying Health System Change and Memorial Sloan-Kettering Cancer Center.
All money raised from the program in Massachusetts, New Hampshire, Connecticut, and Rhode Island will directly benefit the Jimmy Fund and the Stop & Shop Family Pediatric Brain Tumor Clinic at Dana-Farber Cancer Institute; and in observance of a seven-year tradition, all money raised from the Triple Winner Game in New York and New Jersey will directly benefit Memorial Sloan-Kettering Cancer Center.
Traditional homeopathic remedies are so diluted that a dose is unlikely to contain even a single molecule of the original substance, which "makes it pretty unlikely that they're of any value at all," says researcher Andrew Vickers of the Memorial Sloan-Kettering Cancer Center in New York City.
Innovive licensed worldwide development rights for INNO-305 in January 2006 from Memorial Sloan-Kettering Cancer Center in New York.
Full browser ?